Table 1.
Assay Manufacturer | Immunoglobulin classes detected | Antigens used | ||||
---|---|---|---|---|---|---|
Epitope diagnostics Inc. | IgG | Recombinant full length nucleocapsid protein | ||||
Abbott Architect | IgG | Recombinant full length nucleocapsid protein | ||||
Euroimmun AG | IgA | IgG | S1-Domain of Spike protein including receptor-binding domain | |||
Vircell S.L.U. | IgG | Recombinant antigens from Spike glycoprotein and nucleocapsid protein | ||||
Mikrogen GmbH | IgG | Recombinant full length nucleocapsid protein | ||||
in-house ELISA | IgA | IgG | IgM | Full length spike glycoprotein | ||
Genspeed Biotech | IgG | Receptor Binding Domain / Full length spike glycoprotein / Nucleoprotein |
Characteristics of different SARS-CoV-2 assays used in this study.